Ipsen SA, of Paris, reported initial results on phase III study of Dysport in the treatment of adults suffering from upper limb spasticity at the 8th World Congress for Neurorehabilitation in Istanbul. Four weeks after Dysport injection, results demonstrated a statistically significantly higher proportion of responders in muscle tone improvement vs. placebo.